Jr. Clinical Trials Data Specialist

Illinois, United States

Apply with AI Apply

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Precision MedicineIndustries

Requirements

Candidates should possess a Bachelor's or Master's degree in Genetics, Molecular Genetics, Cancer Biology, or Biological Sciences. They must demonstrate strong written and verbal communication skills, proficiency in critical thinking, interpersonal, and problem-solving abilities, and the capacity to manage complex tasks efficiently under time constraints. A high degree of detail-orientation with a commitment to accuracy and consistency is essential, along with self-motivation and the ability to thrive both independently and collaboratively. A passion for making an impact in a fast-paced, mission-driven environment is also required. Experience reviewing hematology/oncology clinical records and critically evaluating clinical trials are preferred qualifications, as is basic knowledge of generative AI.

Responsibilities

The Jr. Clinical Trials Data Specialist will review patient clinical records to determine clinical trial matches and independently manage clinical trial workflows, adapting to changing priorities. They will collaborate with cross-functional teams to create customized clinical reports, synthesizing information from multiple data sources and systems to ensure accuracy, clarity, and alignment with requirements. The role involves supporting ongoing and future projects, contributing to a dynamic work environment through flexibility and responsiveness, and performing other assigned duties.

Skills

clinical trial matching

workflow management

clinical reporting

data synthesis

hematology

oncology

critical evaluation of clinical trials

Genetics

Molecular Genetics

Cancer Biology

Biological Sciences

critical thinking

problem-solving

detail-oriented

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free